摘要
目的:探讨噻托溴铵治疗老年人稳定期慢性阻塞性肺疾病疗效。方法:将63例稳定期慢性阻塞性肺疾病患者随机分为两组,治疗组与对照组分别采用噻托溴铵、异丙托溴铵治疗,疗程2月,观察临床症状、肺功能改善情况。结果:治疗组临床症状、肺功能改善情况优于对照组(P<0·05)。结论:噻托溴铵治疗稳定期慢性阻塞性肺疾病的疗效优于异丙托溴铵,可作稳定期慢阻肺治疗的首选药物。
Objective： To study the clinical effect of tiotropium in treating stable chronic obstructive pulmonary disease. Methods： 63 patients are randomly divided into two groups, and treated by tiotropium and ipralropium respectively for 2 months, and point clinical symptom and pulmonary function are also observed. Results： There is a significant difference between treating group and control group in clinical symptom and pulmonary function changes （ P 〈 0.05）. Conclusion： Tiotropium is a preferred durg for COPD patients in stable phase, it is better than ipralropium in treating COPD.
出处
《华西医学》
CAS
2008年第3期582-583,共2页
West China Medical Journal
